Drug Approval in the European Union and United States

Gary Walsh

doi:10.1002/9783527632909.ch11

Drug Approval in the European Union and United States

Gary Walsh

Department of Chemical Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Original language	English
Title of host publication	Pharmaceutical Biotechnology
Subtitle of host publication	Drug Discovery and Clinical Applications
Publisher	Wiley-VCH
Pages	257-267
Number of pages	11
ISBN (Print)	9783527329946
DOIs	https://doi.org/10.1002/9783527632909.ch11
Publication status	Published - 17 Apr 2012

Keywords

Biosimilar
Drug approval
EMA
FDA
ICH

Access to Document

10.1002/9783527632909.ch11

Cite this

@inbook{00814a28a0494862b5adff278360c0ba,

title = "Drug Approval in the European Union and United States",

keywords = "Biosimilar, Drug approval, EMA, FDA, ICH",

author = "Gary Walsh",

year = "2012",

month = apr,

day = "17",

doi = "10.1002/9783527632909.ch11",

language = "English",

isbn = "9783527329946",

pages = "257--267",

booktitle = "Pharmaceutical Biotechnology",

publisher = "Wiley-VCH",

}

TY - CHAP

T1 - Drug Approval in the European Union and United States

AU - Walsh, Gary

PY - 2012/4/17

Y1 - 2012/4/17

KW - Biosimilar

KW - Drug approval

KW - EMA

KW - FDA

KW - ICH

UR - https://www.scopus.com/pages/publications/84885548874

U2 - 10.1002/9783527632909.ch11

DO - 10.1002/9783527632909.ch11

M3 - Chapter

AN - SCOPUS:84885548874

SN - 9783527329946

SP - 257

EP - 267

BT - Pharmaceutical Biotechnology

PB - Wiley-VCH

ER -

Drug Approval in the European Union and United States

Keywords

Access to Document

Other files and links

Cite this